Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Gabelli 18th Annual Sports & Media Symposium Agenda Released

May 14, 2026

BranchOut Food Shareholder Update: Record Production and Major Customer Deliveries Position Company for Record Q2

May 14, 2026

BitFuFu Announces April 2026 Bitcoin Production and Operational Updates

May 14, 2026

Jackery Brings the Power and Savings to Memorial Day Weekend

May 14, 2026

Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans

May 14, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Appen’s Annual State of AI Report Finds 10% Increase in Bottlenecks Related to Sourcing, Cleaning and Labeling Data
Press Release

Appen’s Annual State of AI Report Finds 10% Increase in Bottlenecks Related to Sourcing, Cleaning and Labeling Data

By News RoomOctober 22, 20244 Mins Read
Appen’s Annual State of AI Report Finds 10% Increase in Bottlenecks Related to Sourcing, Cleaning and Labeling Data
Share
Facebook Twitter LinkedIn Pinterest Email

KIRKLAND, Wash., Oct. 22, 2024 (GLOBE NEWSWIRE) — Appen Limited (ASX: APX), a leading provider of high-quality data for the AI lifecycle, today released the findings of its 2024 State of AI report, which surveyed more than 500 IT decision-makers across a variety of U.S. industries. While growing, the adoption of AI-powered technologies such as machine learning (ML) and generative AI (GenAI) are hindered by a lack of accurate and high-quality data. The report found a 10 percentage point year-over-year increase in bottlenecks related to sourcing, cleaning, and labeling data.

“Enthusiasm around GenAI and other AI-powered tech remains high, as indicated by the rapid growth, but users are quickly finding that the promise of these tools is matched by an equally daunting challenge,” said Si Chen, VP of Strategy at Appen. “The success of AI initiatives relies heavily on high-quality data, and this is becoming more difficult as AI use cases increase in complexity and become more specialized. This is reflected by the fact that high-quality annotations, meaning high consistency and accuracy, are the top features companies seek in a data annotation solution. Those building the AI tools and models of tomorrow value strategic data partnerships now more than ever.”

The report found that the use of GenAI continues to grow at a healthy pace, with adoption up 17 percentage points in 2024 versus the previous year. At the same time, 86% of respondents retrain or update their ML models at least once every quarter, indicating a critical desire for fresh, relevant and high-quality data as accuracy declines. Meanwhile, data accuracy has decreased by 9 percentage points since 2021, making the quest for high-quality data a major challenge—as models are being iterated more frequently, data remains the most significant challenge, especially where accuracy and availability are concerned.

To compile the 2024 State of AI report, Appen commissioned Harris Poll to conduct an online survey of U.S. information technology decision-makers, including business leaders and managers, data scientists, data engineers and developers from April 18 – May 9, 2024, with respondents working at companies with 100-plus employees. Key findings include:

  • Enterprise deployments and ROI are down – mean percent of AI projects making it to deployment has dropped by 8 percentage points since 2021, while the mean percent of deployed AI projects that have shown meaningful ROI has dropped by 9.4 percentage points.
  • Nearly 90% of respondents rely on external data providers for AI model training and/or annotation, underscoring the essential role external data plays in sustaining AI systems.
  • Despite GenAI’s rapid growth, managing bias and ensuring fairness in GenAI model training remains a key challenge. Custom data collection is the primary method for sourcing GenAI training data.
  • Humans are more vital to AI than most might expect: 80% of respondents highlight the importance of human-in-the-loop ML, validating that human insight is key to refining AI systems.
  • Data diversity is the most valued feature in AI, closely followed by efforts to reduce bias and ensure scalability. 97% of respondents agree these elements are vital for building AI models.
  • Data management has emerged as the leading obstacle in AI projects for technologists, with a reported 10 percentage point increase in bottlenecks related to sourcing, cleaning, and labeling data since 2023. Data accuracy has declined by 9 percentage points, likely driven by the increasing complexity of AI and the corresponding data requirements. The lack of data availability has also risen by 7 percentage points during the same period.

The survey results reflect the complex and multifaceted journey to AI success. From the need for high-quality human-in-the-loop data to the challenges of managing bias and ensuring fairness, organizations face numerous obstacles in their pursuit of reliable and effective AI systems.

For more findings from Appen’s 2024 State of AI report, download the full report, review our blog post, or contact us to learn how Appen can support your AI initiatives.

About Appen
Appen (ASX:APX) is the global leader in data for the AI lifecycle with more than 25 years’ experience in data sourcing, annotation and model evaluation. Through our expertise, platform and global crowd, we enable organizations to launch the world’s most innovative artificial intelligence products with speed and at scale. Appen maintains the industry’s most advanced AI-assisted data annotation platform and boasts a global crowd of more than 1 million contributors worldwide, speaking more than 235 languages. Our products and services make Appen a trusted partner to leaders in technology, automotive, finance, retail, healthcare and government. Appen has customers and offices globally.

Contacts
BOCA Communications for Appen
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/622c4348-d46e-4726-9e52-f9cbef2940a2

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Gabelli 18th Annual Sports & Media Symposium Agenda Released

BranchOut Food Shareholder Update: Record Production and Major Customer Deliveries Position Company for Record Q2

BitFuFu Announces April 2026 Bitcoin Production and Operational Updates

Jackery Brings the Power and Savings to Memorial Day Weekend

Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans

Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program

Easy Environmental Solutions & Terreplenish® Show Outstanding Yield Increases & Offer Alternative To Petroleum-Based Fertilizers

PruittHealth Certified as a Great Place to Work for Fifth Consecutive Year

AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer

Editors Picks

BranchOut Food Shareholder Update: Record Production and Major Customer Deliveries Position Company for Record Q2

May 14, 2026

BitFuFu Announces April 2026 Bitcoin Production and Operational Updates

May 14, 2026

Jackery Brings the Power and Savings to Memorial Day Weekend

May 14, 2026

Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans

May 14, 2026

Latest News

EV, hybrid sales 75% higher than March 2025 as gas prices near records

May 14, 2026

Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program

May 14, 2026

Easy Environmental Solutions & Terreplenish® Show Outstanding Yield Increases & Offer Alternative To Petroleum-Based Fertilizers

May 14, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version